Family summary
Current shortage references are available across related Bivalirudin presentations from multiple manufacturers.
- 3 current shortage context pages.
- 0 historical shortage context pages.
- 3 manufacturers represented.
Public shortage context is available across 3 visible exact NDC pages for this generic family.
This family page is organized from FDA/openFDA shortage records and other publicly available source material, then indexed by generic drug name, manufacturer, NDC, and package details for faster browsing.
Current shortage references are available across related Bivalirudin presentations from multiple manufacturers.
These exact presentation links are useful for brand-name, size, and NDC-specific searches related to this shortage family.
Use the exact NDC page when your team needs package-level product details, public shortage references, and the strongest route into RFQ and sourcing workflows. These links open directly to the Drug Shortage Information section for each product page.
| Drug Name | NDC 11 | Manufacturer | Shortage Context |
|---|---|---|---|
| bivalirudin 250 mg / 5mL Injection 5 mL NDC 16729-0275-67 | 10 Vial, Single-Use | Accord Healthcare, Inc. | 16729-0275-67 | Accord Healthcare, Inc. | Current shortage context |
| bivalirudin 250 mg / 1 Injection 10 Injection, Powder, Lyophilized, For Suspension NDC 70436-0025-82 | 10 Injection, Powder, Lyophilized, For Suspension | Slate Run Pharmaceuticals, LLC | 70436-0025-82 | Slate Run Pharmaceuticals, LLC | Current shortage context |
| Bivalirudin 250 mg / 1 Injection 10 Vial, Single-Dose NDC 55150-0210-10 | 10 Vial, Single-Dose | Eugia US LLC | 55150-0210-10 | Eugia US LLC | Current shortage context |
Unless explicitly stated in writing, no direct affiliation, sponsorship, or endorsement by individual product manufacturers with Premium Rx National, LLC should be implied. All brand names, trade names, and trademarks are the property of their respective owners and are presented solely for accurate product identification and informational reference.